(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

NOVOS ANTICORPOS ANTI-CLDN18.2

Em AnáliseInvention PatentPCT · CN2020110220

Application data

Number

112022003147

Type

Invention Patent

Filing

08/20/2020

Publication

05/17/2022

PCT

CN2020110220

Progress at the INPI

  1. Filing08/20/20
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 08/20/2020. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 07/01/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

SUZHOU TRANSCENTA THERAPEUTICS CO., LTD.

CN

TRANSCENTA HOLDING LIMITED

KY

TRANSCENTA THERAPEUTICS, INC.

US

Inventors

F. T. (pessoa física)

CN

H. L. (pessoa física)

CN

H. G. (pessoa física)

CN

H. C. (pessoa física)

CN

X. Q. (pessoa física)

CN

Z. L. (pessoa física)

CN

Technical data

Priority claims

CN

PCT/CN2019/101563 · 08/20/2019

CN

PCT/CN2020/097559 · 06/22/2020

Abstract

NOVOS ANTICORPOS ANTI-CLDN18.2. A presente invenção refere-se a anticorpos anti-CLDN18.2 ou fragmentos de ligação ao antígeno dos mesmos, polinucleotídeos isolados que codificam os mesmos, composições farmacêuticas compreendendo os mesmos e seus usos.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Transferência deferida

#25.1

07/01/2025

RPI 2843

Notificação de entrada na fase nacional - PCT

#1.3

05/17/2022

RPI 2680

Alteração de dados cadastrais

#1.1

03/03/2022

RPI 2669

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.